MEAKSS, a synthetic peptide, is emerging as a promising therapeutic for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates significant neuroprotective effects by regulating key cellular pathways involved in neuronal survival. Studies suggest that MEAKSS can promote synaptogenesis, {reduceinflammation, and optimize